25 Sep 2018 12:12
The announcement originally released on 25/09/18 at 11.23am under RNS No 8523B has been amended. Amendment has been identified with an asterisk (*).
All other details remain unchanged.
The full amended text is shown below.
Nucleus Financial Group plc
("Nucleus")
Director share purchase
Nucleus (AIM: NUC) announces that, pursuant to the notification obligations in accordance with Article 19 of the Market Abuse Regulation (MAR), it has received notification that on 21 September 2018, Angus Samuels, Non-executive Chairman, purchased 26,704 ordinary shares of 0.1p each ("Ordinary Shares") for an average price of 176p. As a result, Mr Samuels is interested in 26,704 Ordinary Shares, representing 0.03% of the Company's issued share capital.
The Company has also been notified of an acquisition of ordinary shares by the spouse of Angus Samuels, Non-executive chairman, Katy Samuels, a "person closely associated" for the purposes of MAR.
1. | Details of PDMR / person closely associated with them ('PCA') | ||||||
a) | Name | James Anthony Angus Samuels | |||||
2. | Details of PDMR / person closely associated with them ('PCA') | ||||||
a) | Position / status | Non-executive company chairman | |||||
b) | Initial notification / amendment | Initial notification * | |||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
a) | Name | Nucleus Financial Group plc | |||||
b) | LEI | 213800MAIAI3M7LM5950 | |||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
c) | Description of the financial instrument | Ordinary shares of 0.1p
ISIN: GB00BG226J60 | |||||
d) | Nature of the transaction | Acquisition | |||||
e) | Price(s) and volume(s) |
| |||||
f) | Aggregated information
Aggregated volume
Price |
26,704
£46,999.04
| |||||
g) | Date of the transaction | 21 September 2018
| |||||
h) | Place of the transaction | LONDON STOCK EXCHANGE XLON
| |||||
3. | Details of PDMR / person closely associated with them ('PCA') | ||||||
a) | Name | Katy Samuels | |||||
4. | Details of PDMR / person closely associated with them ('PCA') | ||||||
a) | Position / status | PCA | |||||
b) | Initial notification / amendment | Initial notification | |||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
a) | Name | Nucleus Financial Group plc | |||||
b) | LEI | 213800MAIAI3M7LM5950 | |||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
c) | Description of the financial instrument | Ordinary shares of 0.1p
ISIN: GB00BG226J60
| |||||
d) | Nature of the transaction | Acquisition | |||||
e) | Price(s) and volume(s) |
| |||||
f) | Aggregated information
Aggregated volume
Price |
26,705
£47,000.80 | |||||
g) | Date of the transaction | 21 September 2018
| |||||
h) | Place of the transaction | LONDON STOCK EXCHANGE XLON
| |||||
Nucleus
David Ferguson, CEO Tel: +44 (0)13 1226 9800
Stuart Geard, Chief Financial Officer
Shore Capital (Nominated Adviser and Broker)
Hugh Morgan Tel: +44 (0)20 7408 4090
Edward Mansfield
Daniel Bush
Camarco (Media enquiries)
Jennifer Renwick Tel: +44 (0)20 3757 4994
Jake Thomas